Efficacy of Oral DFD-29, a Low-Dose Minocycline Formulation, in Patients in Germany and Patients in the US: An Analysis of Two Phase 3 Trials. (2026). SKIN The Journal of Cutaneous Medicine, 10(2), s765. https://doi.org/10.25251/kf0b7204